Developer docs
API playgroundTry for free, no card

Search company profiles

Proxsys Rx

Full company profile

uuid0008iq1

Namestring
Proxsys Rx
Websiteurl
proxsysrx.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Proxsys Rx is a private, for-profit healthcare services company founded in 2013 and headquartered in Birmingham, Alabama. Per its stated company description, it provides healthcare systems with solutions aimed at reducing hospital readmissions, positioning its value proposition around long-term cost savings for its clients rather than around any specific software product, device, or pharmaceutical. The company operates at a mid-stage scale, with headcount in the 101-250 range.

The company's business model appears to be a B2B service offering sold to U.S. healthcare systems, though pricing mechanics — whether the company charges per-bed, per-discharge, on a shared-savings basis tied to CMS Hospital Readmissions Reduction Program penalties, or via subscription — are not disclosed in the available data. The published company description frames the offering in cost-saving terms, which is consistent with either a fee-for-service consulting/delivery model or a value-based / risk-sharing arrangement tied to reduced readmission rates.

Leadership is concentrated in founder George Salem, who serves as Founder & CEO. The company's capital structure includes a 2020 financing led by Fulcrum Equity Partners, a healthcare-focused lower-middle-market private equity firm. Notably, substantive company information — including product detail, technology stack, customer logos, pricing, and revenue — could not be retrieved because the company website (proxsysrx.com) returned a verification challenge rather than content, representing a significant data gap for any deeper diligence.

Short descriptiontext

Proxsys Rx is a Birmingham-based healthcare solutions company that helps U.S. healthcare systems reduce hospital readmissions to deliver long-term cost savings.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBirmingham, United States
HQ citystring
Birmingham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
readmission reduction software, medication management platform, care transition solutions, post-discharge pharmacy services, hospital readmission prevention
Industry2 codes
PRIMARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Hospital Readmission Management
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Proxsys Rx is a healthcare solutions company that provides health care systems with long-term cost savings by reducing hospital readmissions. The company delivers post-discharge medication management and care transition services designed to keep patients healthy after they leave the hospital, thereby lowering avoidable readmissions and the associated financial penalties for hospitals.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Readmission Reduction Program
CategoryCare Transitions / Medication Management
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
1Health Recovery Solutions
TypeDirect peer
TypeDirect peer
Description

Medication management and pharmacy-led solutions provider targeting health systems and PACE programs to reduce adverse drug events and readmissions. Closely comparable to Proxsys Rx as a pharmacy-services company addressing the same buyer and same readmission KPI.

TypeBroad incumbent
Description

Provides in-home health evaluations and post-acute care services (incorporating Remedy Partners) targeting readmission reduction for payers and providers. Competes with Proxsys Rx for hospital and payer budgets tied to post-discharge management, with broader payer relationships and national reach.

TypeDirect peer
Description

Patient engagement and care transitions platform used by hospitals to reduce readmissions through post-discharge outreach and follow-up. Targets the same health system buyer and readmission KPI as Proxsys Rx.

TypeBroad incumbent
Description

Healthcare IT platform spanning care coordination, post-acute, and hospital software. Competes with Proxsys Rx for hospital budgets allocated to care transitions and readmission reduction, but with much broader product breadth.

TypeDirect peer
Description

Clinical pharmacist services marketplace delivering medication management to patients post-discharge. Shares the pharmacy-led, health-system-customer, readmission-reduction thesis with Proxsys Rx.

TypeBroad incumbent
Description

Post-acute care management platform owned by UnitedHealth/Optum that partners with hospitals and health plans to reduce readmissions. Directly competes with Proxsys Rx for the same health system buyer and the same readmission-reduction outcome, but at significantly greater scale and breadth.

8Collective Medical (PointClickCare)
TypeBroad incumbent
Description

Care coordination and patient event notification platform used by hospitals to manage care transitions and reduce avoidable readmissions. Overlaps with Proxsys Rx for hospital customers and the readmission-reduction use case.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Proxsys Rx

Hospital Readmission Managementproxsysrx.com

Proxsys Rx is a Birmingham-based healthcare solutions company that helps U.S. healthcare systems reduce hospital readmissions to deliver long-term cost savings.

What Proxsys Rx does

Proxsys Rx is a private, for-profit healthcare services company founded in 2013 and headquartered in Birmingham, Alabama. Per its stated company description, it provides healthcare systems with solutions aimed at reducing hospital readmissions, positioning its value proposition around long-term cost savings for its clients rather than around any specific software product, device, or pharmaceutical. The company operates at a mid-stage scale, with headcount in the 101-250 range.

The company's business model appears to be a B2B service offering sold to U.S. healthcare systems, though pricing mechanics — whether the company charges per-bed, per-discharge, on a shared-savings basis tied to CMS Hospital Readmissions Reduction Program penalties, or via subscription — are not disclosed in the available data. The published company description frames the offering in cost-saving terms, which is consistent with either a fee-for-service consulting/delivery model or a value-based / risk-sharing arrangement tied to reduced readmission rates.

Leadership is concentrated in founder George Salem, who serves as Founder & CEO. The company's capital structure includes a 2020 financing led by Fulcrum Equity Partners, a healthcare-focused lower-middle-market private equity firm. Notably, substantive company information — including product detail, technology stack, customer logos, pricing, and revenue — could not be retrieved because the company website (proxsysrx.com) returned a verification challenge rather than content, representing a significant data gap for any deeper diligence.

Proxsys Rx firmographics

Firmographics
Name
Proxsys Rx
Website
https://proxsysrx.com
Company type
Private
Founded year
2013
Headcount range
101–250 employees
Short description
Proxsys Rx is a Birmingham-based healthcare solutions company that helps U.S. healthcare systems reduce hospital readmissions to deliver long-term cost savings.
Ownership category
akta.pro rank

Proxsys Rx industry classification

Industry
Product category
Hospital Readmission Management
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Readmission reduction software
  • Medication management platform
  • Care transition solutions
  • Post-discharge pharmacy services
  • Hospital readmission prevention

Where Proxsys Rx is headquartered

Location

Headquarters

HQ city
Birmingham
HQ country
United States
HQ region
North America

Markets served

Proxsys Rx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Proxsys Rx product offering

Product offering

Core offering

Proxsys Rx is a healthcare solutions company that provides health care systems with long-term cost savings by reducing hospital readmissions. The company delivers post-discharge medication management and care transition services designed to keep patients healthy after they leave the hospital, thereby lowering avoidable readmissions and the associated financial penalties for hospitals.

Differentiator

Problem solved

Functional benefit

Products and services

  • Readmission Reduction Program

Companies that use Proxsys Rx

Customer profile

Ideal customer profiles1 record

Proxsys Rx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Proxsys Rx partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights3 records

Proxsys Rx competitors and assessment

Company assessment

Direct peers

  • Health Recovery Solutions:
  • Tabula Rasa HealthCare: Medication management and pharmacy-led solutions provider targeting health systems and PACE programs to reduce adverse drug events and readmissions. Closely comparable to Proxsys Rx as a pharmacy-services company addressing the same buyer and same readmission KPI.
  • CipherHealth: Patient engagement and care transitions platform used by hospitals to reduce readmissions through post-discharge outreach and follow-up. Targets the same health system buyer and readmission KPI as Proxsys Rx.
  • Aspen RxHealth: Clinical pharmacist services marketplace delivering medication management to patients post-discharge. Shares the pharmacy-led, health-system-customer, readmission-reduction thesis with Proxsys Rx.

Broad incumbents

  • Signify Health: Provides in-home health evaluations and post-acute care services (incorporating Remedy Partners) targeting readmission reduction for payers and providers. Competes with Proxsys Rx for hospital and payer budgets tied to post-discharge management, with broader payer relationships and national reach.
  • WellSky: Healthcare IT platform spanning care coordination, post-acute, and hospital software. Competes with Proxsys Rx for hospital budgets allocated to care transitions and readmission reduction, but with much broader product breadth.
  • naviHealth (Optum): Post-acute care management platform owned by UnitedHealth/Optum that partners with hospitals and health plans to reduce readmissions. Directly competes with Proxsys Rx for the same health system buyer and the same readmission-reduction outcome, but at significantly greater scale and breadth.
  • Collective Medical (PointClickCare): Care coordination and patient event notification platform used by hospitals to manage care transitions and reduce avoidable readmissions. Overlaps with Proxsys Rx for hospital customers and the readmission-reduction use case.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Proxsys Rx social profiles

Digital presence

Proxsys Rx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Proxsys Rx leadership team

Management profile

Number of profiles

Profiles1 record

Proxsys Rx funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Proxsys Rx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Proxsys Rx

What does Proxsys Rx do?

Proxsys Rx is a healthcare solutions company that provides health care systems with long-term cost savings by reducing hospital readmissions. The company delivers post-discharge medication management and care transition services designed to keep patients healthy after they leave the hospital, thereby lowering avoidable readmissions and the associated financial penalties for hospitals.

When was Proxsys Rx founded?

Proxsys Rx was founded in 2013. It employs 101 to 250 people.

Where is Proxsys Rx based?

Proxsys Rx is headquartered in Birmingham, United States, in the North America region.

Who are Proxsys Rx's main competitors?

Direct peers on record are Health Recovery Solutions, Tabula Rasa HealthCare, CipherHealth and Aspen RxHealth. Broad incumbents are Signify Health, WellSky, naviHealth (Optum) and Collective Medical (PointClickCare).

Does Proxsys Rx have an API?

No public API is recorded for Proxsys Rx.

What industry is Proxsys Rx in?

Proxsys Rx's product category is Hospital Readmission Management. Its primary akta.pro industry code is HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement, with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dallas InnovatesPlano's Maxor National Pharmacy Services Appoints New CEO, Combines With ProxsysRxMaxor National Pharmacy Services appointed Kim Tzoumakas as CEO, succeeding Mike Ellis, and announced a strategic combination with ProxsysRx. The merger aims to accelerate Maxor's Pharmacy Services segment and position it as the largest independent pharmacy management provider. Tzoumakas will lead the combined organization, with ProxsysRx CEO George Salem transitioning to a board observer role.PR NewswireProxsysRx Signs Contract To Build And Manage Specialty Pharmacy For South Carolina's Conway Medical CenterProxsysRx has signed a contract with Conway Medical Center to build and manage an on-campus specialty pharmacy at the 210-bed South Carolina hospital, marking the fifth hospital for which the Birmingham-based company has been contracted to provide this service. The announcement comes shortly after ProxsysRx became the fourth company awarded URAC accreditation for specialty pharmacy and the only company offering health systems a comprehensive range of pharmacy-related support services. The specialty pharmacy will enable the hospital to enhance care for high-need patients while expanding savings through its 340B prescription program, which has already generated millions in savings and revenue for Conway Medical Center since 2019.PR NewswireProxsysRx earns URAC Accreditation for specialty pharmacy servicesProxsysRx, a Birmingham-based specialty pharmacy services company, has earned URAC accreditation status, becoming only the fourth company and the only one offering comprehensive pharmacy-related support services to health systems to achieve this distinction. The six-month validation process requires organizations to meet all mandatory measures and score 94% or higher, and reduces the time hospitals typically spend on specialty pharmacy accreditation from 12 months to approximately six months. The accreditation validates ProxsysRx's clinical patient management, quality management, and data security practices, including call center service standards requiring all calls to be answered within 30 seconds.American City Business JournalsProxsysRx gets specialty pharmacy contract with Massachusetts hospitalProxsysRx will open a specialty pharmacy at Holyoke Medical Center in Massachusetts, following a prior retail pharmacy contract. The company now serves 32 hospital systems and has raised $14.5 million in Series A funding. The specialty pharmacy aims to expand 340B savings for patients.ProxsysrxSpecialty PharmacyProxsysRx has rebranded as VytlOne, a company that provides consultative and operational support for healthcare systems looking to establish onsite specialty pharmacies. The entity offers services including 340B program optimization, PBM alignment, and financial modeling to help hospitals fund these pharmacies using generated savings rather than upfront capital.AiThorityProxsysRx Receives Growth Equity Investment to Accelerate ExpansionProxsysRx received a growth equity investment from Fulcrum Equity Partners, with management participation. The funding will accelerate technological development, expand into new U.S. markets, and add infrastructure. Fulcrum partners Tom Greer and Jeff Muir will join the board.FinSMEsProxsysRx Receives Equity InvestmentProxsysRx, a Birmingham, Ala.-based healthcare solutions company, received a growth equity investment from Atlanta-based Fulcrum Equity Partners with management participation. The deal amount was not disclosed, and Fulcrum partners Tom Greer and Jeff Muir will join the board. The funding will accelerate technological developments, expand the footprint to new U.S. markets, and provide additional infrastructure.PR NewswireProxsys Rx and Pack Health Outline Program That Reduced Hospital Readmissions By Nearly 40%Proxsys Rx and Pack Health announced results from a yearlong collaboration to reduce hospital readmissions at a rural hospital system in the Southeast, yielding a 38% reduction in readmissions for patients who engaged in the program post-discharge. The program enrolled roughly 20% of the hospital's discharged Medicare A population, with Pack Health engaging 50% of that group; only 3% of those who completed the program were readmitted versus 22% for those who declined or could not be contacted. Cost savings are estimated to surpass $300,000, and the organizations are expanding the PaaS Readmissions program into other health systems to help hospitals control costs associated with 30-day readmissions.PrwebProxsys Rx Provides Southwest Mississippi Regional Medical Center with New Technology to Improve Community HealthProxsys Rx and Southwest Mississippi Regional Medical Center announced a partnership to integrate outpatient pharmacy services into the hospital's continuum of care. The collaboration aims to reduce readmissions, lower prescription drug costs, and improve patient experience scores, with savings passed to patients.PR NewswireProxsys Rx Opens Pharmacy at DeSoto - Technology Drives Patient BenefitsProxsys Rx announced the opening of The Pharmacy at DeSoto, an outpatient retail pharmacy at Baptist Memorial Hospital-DeSoto in Southaven, Mississippi, on June 16, 2016. The pharmacy will partner with the hospital to provide transitional patient care services including bedside pharmacy counseling, medication compliance support, and programs designed to reduce hospital readmissions while generating cost savings. Benefits include pharmacist consultations via digital app, easier medication access, and discounted pricing for patients.